Skip to content
drillr.ai
Sign up

TNON

Tenon Medical, Inc.

NASDAQ · Healthcare · Medical - Devices · US

$4.08
−2.86%
Ask drillr

  • Sep 11, 2026, 17:22 UTC

    Tenon Medical entered into warrant exercise agreements with an institutional investor to exercise existing warrants for 572,179 shares for gross proceeds of about $2.87 million and issued new warrants for up to 858,269 shares at $5.02 per share in a private placement.

    Source:

  • Sep 9, 2026, 12:30 UTC

    Tenon Medical, Inc. announced it has repaid in full its outstanding original issue discount senior convertible promissory notes, with an aggregate principal balance of approximately $5.16 million, ahead of their September 11, 2026 maturity date.

    Source:

  • Aug 28, 2026, 12:15 UTC

    Tenon Medical entered into a securities purchase agreement to sell 597,610 shares of common stock (or pre-funded warrants) and warrants for up to 1,058,517 shares in a private placement at a combined effective price of $5.02 per share.

    Source:

  • Aug 14, 2026, 01:57 UTC

    Tenon Medical plans to launch sacropelvic products over the next six to nine months following FDA 510(k) clearance.

    Source:

  • Aug 13, 2026, 20:05 UTC

    Tenon Medical received FDA 510(k) clearance for its updated Catamaran SI Joint Fusion System.

    Source:

  • Aug 13, 2026, 20:05 UTC

    Tenon Medical reported second quarter 2026 revenue of $1.3 million, a 127% increase from $0.6 million in the prior year, and gross profit of $0.8 million with a 64% gross margin.

    Source:

  • Aug 6, 2026, 12:30 UTC

    Tenon Medical, Inc. announced a 1-for-35 reverse stock split of its common stock, effective August 10, 2026.

    Source:

  • Jun 30, 2026, 13:25 UTC

    Tenon Medical, Inc. priced a public offering of common stock and warrants for aggregate gross proceeds of approximately $4.2 million.

    Source: